Physician profile
Christopher Lyn Reece
NPI 1710330493
$2,661.94
in general payments reported to CMS, 2019-2025
7 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $1,528 · 2024: $1,134.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,600 · Travel and Lodging: $1,009 · Education: $52.85.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,600.46 |
| Travel and Lodging | $1,008.63 |
| Education | $52.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,480.32 | 2023-2024 | Vanta Adaptivestim, Intellis Adaptivestim |
| Mml US, INC. | $462.60 | 2023-2024 | Reactiv8 |
| Biotronik Nro, INC. | $221.76 | 2024 | Prospera |
| Abbott Laboratories | $203.99 | 2024 | Proclaim |
| Nalu Medical, INC. | $132.36 | 2024 | Nalu Neurostimulation System |
| Boston Scientific Corporation | $118.38 | 2024 | |
| Spr Therapeutics, INC | $42.53 | 2023 | Sprint Pns System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Reece listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.